SCHEMBL9864992

SCHEMBL9864992

CC(CSCc1ccccn1)NC(=NCCCc1c[nH]cn1)NC(=O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 1/20 0.40
ALDH1A1 P00352 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
RAB9A P51151 2/20 0.36
CYP1A2 P05177 2/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPK1 P28482 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
CTRB1 P17538 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
CXCR4 P61073 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9866370 0.91 HPGD (0.38) HRH2SMN1; SMN2KMT2AMEN1LMNA
SCHEMBL9866425 0.84 RAB9A (0.42) HRH2ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL9864984 0.82 RAB9A (0.42) HRH2ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL9867306 0.81 MTNR1A (0.42) HRH2ALDH1A1
SCHEMBL9866419 0.81 RAB9A (0.42) HRH2ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL9867255 0.75 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL9865765 0.75 RAB9A (0.47) HRH2ALDH1A1SMN1; SMN2KMT2ARAB9A
SCHEMBL11080978 0.75 HRH2 (0.47) HRH2RAB9AHRH4NPC1
SCHEMBL9866479 0.75 RAB9A (0.42) HRH2ALDH1A1SMN1; SMN2KMT2ARAB9A
SCHEMBL9867649 0.74 LMNA (0.49) HRH2ALDH1A1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed